The Latest Breaking News from Vinay Prasad

Vinay Prasad on Anthony Fauci, COVID-19 Restrictions, and RFK Jr.

"Fauci was wrong about almost every single pandemic policy he advanced," the former FDA insider tells Reason.

Reason · 20h ago

FDA fills four senior roles, including top officials for drugs, vaccines and tobacco

The Trump administration named four officials to take over senior roles at the Food and Drug Administration, including the agency’s top leaders for drugs and vaccines

The Independent UK · Sep 8

Vinay Prasad: Public Health in This Country Is So Broken

Vinay Prasad discusses his departure from the FDA, Fauci's diaries, and how working for the government made him more libertarian.

Reason · Aug 26

The COVID Reckoning Doesn't Go Far Enough

Real medical freedom will require something greater than replacing the public health establishment: ending the FDA's monopoly.

Reason · Apr 21

Trump administration’s embattled FDA vaccine chief departing for the second time

Vinay Prasad to leave in April after decisions involving vaccine reviews and specialty drugs for rare diseases

The Guardian - US · Mar 6

FDA to offer bonus payments to staffers who complete speedy drug reviews

The head of the Food and Drug Administration plans to start offering bonus payments to agency drug reviewers who complete their work ahead of the schedule

The Independent UK · Feb 26

FDA will drop two-study requirement for new drug approvals, aiming to speed access

The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies for new drug approvals

The Independent UK · Feb 18

FDA refuses to consider Moderna flu shot in move experts claim is part of ‘anti-vaccine agenda’

Experts say ‘they’re just coming up with reasons’ as agency says application lacked ‘adequate and well controlled’ trial

The Guardian - US · Feb 13

FDA rejects Moderna’s mRNA flu vaccine application - for reasons with no basis in the law

The Food and Drug Administration has refused to review an application from the biotech company Moderna to approve its mRNA-based flu vaccine.

The Conversation · Feb 12

FDA declines to review Moderna application for new flu vaccine

Moderna requests meeting to discuss refusal as decision could have implications for all new and updated vaccines

The Guardian - US · Feb 10